IC261 is a novel inhibitor of CK1, triggers the mitotic checkpoint control. The IC50 of IC261 for CK1 was 16 M and for Cdk5 is 4.5 mM.
IC261 is a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. At low micromolar concentrations IC261 inhibits cytokinesis causing a transient mitotic arrest. IC261 selectively inhibits CK1 compared to other protein kinases by an ATP-competitive mechanism.
For research use only. We do not sell to patients.
Name | IC261 |
---|---|
Iupac Chemical Name | IC261 |
Synonyms | IC-261; SU-5607 |
Molecular Formula | C18H17NO4 |
Molecular Weight | 311.33 |
Smile | COc1cc(c(c(c1)OC)/C=C/2\c3ccccc3NC2=O)OC |
InChiKey | JBJYTZXCZDNOJW-JLHYYAGUSA-N |
InChi | InChI=1S/C18H17NO4/c1-21-11-8-16(22-2)14(17(9-11)23-3)10-13-12-6-4-5-7-15(12)19-18(13)20/h4-10H,1-3H3,(H,19,20)/b13-10+ |
CAS Number | 186611-52-9 |
MDL | MFCD00118156 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | crystalline solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |